Toll-like receptor driven B cell activation in the induction of systemic autoimmunity

Seminars in Immunology

Volumn 23, Issue 2, 2011, Pages 106-112

  Green, Nathaniel M ^a,b   Marshak Rothstein, Ann ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Autoimmune disease; B cell; SLE; TLR

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; DNA; RNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; HUMAN; IMMUNOPATHOGENESIS; MULTIGENE FAMILY; NONHUMAN; PROTEIN FUNCTION; REVIEW;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; HUMANS; INTERFERON TYPE I; LYMPHOCYTE ACTIVATION; TOLL-LIKE RECEPTORS;

EID: 79953162780     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2011.01.016     Document Type: Review

References (100)

1. von Muhlen C.A., Tan E.M. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995, 24:323-358.
2. Nakamura R.M., Tan E.M. Autoantibodies to nonhistone nuclear antigens and their clinical significance. Hum Pathol 1983, 14:392-400.
3. Chung L., Utz P.J. Antibodies in scleroderma: direct pathogenicity and phenotypic associations. Curr Rheumatol Rep 2004, 6:156-163.
4. Alspaugh M.A., Talal N., Tan E.M. Differentiation and characterization of autoantibodies and their antigens in Sjogren's syndrome. Arthritis Rheum 1976, 19:216-222.
5. Schmid G., Fricke L., Lange H.W., Heidland A. Intracellular histidine content of various tissues (brain, striated muscle and liver) in experimental chronic renal failure. Klin Wochenschr 1977, 55:583-585.
6. Rosa M.D., Hendrick J.P., Lerner M.R., Steitz J.A., Reichlin M. A mammalian tRNAHis-containing antigen is recognized by the polymyositis-specific antibody anti-Jo-1. Nucleic Acids Res 1983, 11:853-870.
7. Rifkin I.R., Leadbetter E.A., Busconi L., Viglianti G., Marshak-Rothstein A. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev 2005, 204:27-42.
8. Emlen W., Niebur J., Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994, 152:3685-3692.
9. Ren Y., Tang J., Mok M.Y., Chan A.W., Wu A., Lau C.S. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum 2003, 48:2888-2897.
10. Radic M., Marion T., Monestier M. Nucleosomes are exposed at the cell surface in apoptosis. J Immunol 2004, 172:6692-6700.
11. Casciola-Rosen L.A., Anhalt G., Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994, 179:1317-1330.
12. Reed J.H., Neufing P.J., Jackson M.W., Clancy R.M., Macardle P.J., Buyon J.P., et al. Different temporal expression of immunodominant Ro60/60 kDa-SSA and La/SSB apotopes. Clin Exp Immunol 2007, 148:153-160.
13. Ramirez-Sandoval R., Vazquez-del-Mercado M., Daneri-Navarro A., Lopez-Robles E., Bollain-y-Goitia J.J., Avalos-Diaz E., et al. Intracellular antigens released from Balb/c mice kidneys under chemically induced apoptosis and/or necrosis. Reumatismo 2008, 60:108-113.
14. Rifkin I.R., Leadbetter E.A., Beaudette B.C., Kiani C., Monestier M., Shlomchik M.J., et al. Immune complexes present in the sera of autoimmune mice activate rheumatoid factor B cells. J Immunol 2000, 165:1626-1633.
15. Leadbetter E.A., Rifkin I.R., Hohlbaum A.M., Beaudette B.C., Shlomchik M.J., Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002, 416:603-607.
16. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010, 11:373-384.
17. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
18. Kim Y.M., Brinkmann M.M., Paquet M.E., Ploegh H.L. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 2008, 452:234-238.
19. Brinkmann M.M., Spooner E., Hoebe K., Beutler B., Ploegh H.L., Kim Y.M. The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J Cell Biol 2007, 177:265-275.
20. Busconi L., Lau C.M., Tabor A.S., Uccellini M.B., Ruhe Z., Akira S., et al. DNA and RNA autoantigens as autoadjuvants. J Endotoxin Res 2006, 12:379-384.
21. Nakano S., Morimoto S., Suzuki S., Watanabe T., Amano H., Takasaki Y. Up-regulation of the endoplasmic reticulum transmembrane protein UNC93B in the B cells of patients with active systemic lupus erythematosus. Rheumatology (Oxford). 2010, 49:876-881.
22. Gursel I., Gursel M., Yamada H., Ishii K.J., Takeshita F., Klinman D.M. Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation. J Immunol 2003, 171:1393-1400.
23. Viglianti G.A., Lau C.M., Hanley T.M., Miko B.A., Shlomchik M.J., Marshak-Rothstein A. Activation of autoreactive B cells by CpG dsDNA. Immunity 2003, 19:837-847.
24. Uccellini M.B., Busconi L., Green N.M., Busto P., Christensen S.R., Shlomchik M.J., et al. Autoreactive B cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-alpha. J Immunol 2008, 181:5875-5884.
25. Diebold S.S., Massacrier C., Akira S., Paturel C., Morel Y., Reis e Sousa C. Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides. Eur J Immunol 2006, 36:3256-3267.
26. Kariko K., Buckstein M., Ni H., Weissman D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 2005, 23:165-175.
27. Forsbach A., Nemorin J.G., Volp K., Samulowitz U., Montino C., Muller C., et al. Characterization of conserved viral leader RNA sequences that stimulate innate immunity through TLRs. Oligonucleotides 2007, 17:405-417.
28. Kelly-Scumpia K.M., Nacionales D.C., Scumpia P.O., Weinstein J.S., Narain S., Moldawer L.L., et al. In vivo adjuvant activity of the RNA component of the Sm/RNP lupus autoantigen. Arthritis Rheum 2007, 56:3379-3386.
29. Weinberg R.A., Penman S. Small molecular weight monodisperse nuclear RNA. J Mol Biol 1968, 38:289-304.
30. Liu W.M., Chu W.M., Choudary P.V., Schmid C.W. Cell stress and translational inhibitors transiently increase the abundance of mammalian SINE transcripts. Nucleic Acids Res 1995, 23:1758-1765.
31. Lau C.M., Broughton C., Tabor A.S., Akira S., Flavell R.A., Mamula M.J., et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med 2005, 202:1171-1177.
32. Vollmer J., Tluk S., Schmitz C., Hamm S., Jurk M., Forsbach A., et al. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J Exp Med 2005, 202:1575-1585.
33. Lee P.Y., Kumagai Y., Li Y., Takeuchi O., Yoshida H., Weinstein J., et al. TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus. J Exp Med 2008, 205:2995-3006.
34. Hoffman R.W., Gazitt T., Foecking M.F., Ortmann R.A., Misfeldt M., Jorgenson R., et al. U1 RNA induces innate immunity signaling. Arthritis Rheum 2004, 50:2891-2896.
35. Gururajan M., Jacob J., Pulendran B. Toll-like receptor expression and responsiveness of distinct murine splenic and mucosal B-cell subsets. PLoS One 2007, 2:e863.
36. Dorner M., Brandt S., Tinguely M., Zucol F., Bourquin J.P., Zauner L., et al. Plasma cell toll-like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production. Immunology 2009, 128:573-579.
37. Marshall-Clarke S., Downes J.E., Haga I.R., Bowie A.G., Borrow P., Pennock J.L., et al. Polyinosinic acid is a ligand for toll-like receptor 3. J Biol Chem 2007, 282:24759-24766.
38. Preble O.T., Black R.J., Friedman R.M., Klippel J.H., Vilcek J. Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science 1982, 216:429-431.
39. Wilson L.E., Widman D., Dikman S.H., Gorevic P.D. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection. Semin Arthritis Rheum 2002, 32:163-173.
40. Baechler E.C., Batliwalla F.M., Karypis G., Gaffney P.M., Ortmann W.A., Espe K.J., et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 2003, 100:2610-2615.
41. Bennett L., Palucka A.K., Arce E., Cantrell V., Borvak J., Banchereau J., et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003, 197:711-723.
42. Li Q.Z., Zhou J., Lian Y., Zhang B., Branch V.K., Carr-Johnson F., et al. Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes. Clin Exp Immunol. 2010, 159:281-291.
43. Chawla-Sarkar M., Lindner D.J., Liu Y.F., Williams B.R., Sen G.C., Silverman R.H., et al. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 2003, 8:237-249.
44. Heer A.K., Shamshiev A., Donda A., Uematsu S., Akira S., Kopf M., et al. TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses. J Immunol 2007, 178:2182-2191.
45. Ehlers M., Fukuyama H., McGaha T.L., Aderem A., Ravetch J.V. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J Exp Med 2006, 203:553-561.
46. Green N.M., Laws A., Kiefer K., Busconi L., Kim Y.M., Brinkmann M.M., et al. Murine B cell response to TLR7 ligands depends on an IFN-beta feedback loop. J Immunol 2009, 183:1569-1576.
47. Bekeredjian-Ding I.B., Wagner M., Hornung V., Giese T., Schnurr M., Endres S., et al. Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J Immunol 2005, 174:4043-4050.
48. Yasuda K., Richez C., Maciaszek J.W., Agrawal N., Akira S., Marshak-Rothstein A., et al. Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production. J Immunol 2007, 178:6876-6885.
49. Litinskiy M.B., Nardelli B., Hilbert D.M., He B., Schaffer A., Casali P., et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 2002, 3:822-829.
50. Treml L.S., Carlesso G., Hoek K.L., Stadanlick J.E., Kambayashi T., Bram R.J., et al. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells. J Immunol 2007, 178:7531-7539.
51. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 1999, 190:1697-1710.
52. Richez C., Yasuda K., Bonegio R.G., Watkins A.A., Aprahamian T., Busto P., et al. IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus. J Immunol. 2010, 184:796-806.
53. Niewold T.B., Kelly J.A., Flesch M.H., Espinoza L.R., Harley J.B., Crow M.K. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Arthritis Rheum 2008, 58:2481-2487.
54. Mackay M., Stanevsky A., Wang T., Aranow C., Li M., Koenig S., et al. Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE. J Exp Med 2006, 203:2157-2164.
55. Avalos A.M., Uccellini M.B., Lenert P., Viglianti G.A., Marshak-Rothstein A. FcgammaRIIB regulation of BCR/TLR-dependent autoreactive B-cell responses. Eur J Immunol. 2010, 40:2692-2698.
56. Nickerson K.M., Christensen S.R., Shupe J., Kashgarian M., Kim D., Elkon K., et al. TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus. J Immunol. 2010, 184:1840-1848.
57. Silver K.L., Crockford T.L., Bouriez-Jones T., Milling S., Lambe T., Cornall R.J. MyD88-dependent autoimmune disease in Lyn-deficient mice. Eur J Immunol 2007, 37:2734-2743.
58. Groom J.R., Fletcher C.A., Walters S.N., Grey S.T., Watt S.V., Sweet M.J., et al. BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med 2007, 204:1959-1971.
59. Burns K., Martinon F., Esslinger C., Pahl H., Schneider P., Bodmer J.L., et al. MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem 1998, 273:12203-12209.
60. He B., Santamaria R., Xu W., Cols M., Chen K., Puga I., et al. The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat Immunol. 2010, 11:836-845.
61. Kono D.H., Haraldsson M.K., Lawson B.R., Pollard K.M., Koh Y.T., Du X., et al. Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus. Proc Natl Acad Sci USA 2009, 106:12061-12066.
62. Christensen S.R., Shupe J., Nickerson K., Kashgarian M., Flavell R.A., Shlomchik M.J. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 2006, 25:417-428.
63. Berland R., Fernandez L., Kari E., Han J.H., Lomakin I., Akira S., et al. Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. Immunity 2006, 25:429-440.
64. Subramanian S., Tus K., Li Q.Z., Wang A., Tian X.H., Zhou J., et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci USA 2006, 103:9970-9975.
65. Pisitkun P., Deane J.A., Difilippantonio M.J., Tarasenko T., Satterthwaite A.B., Bolland S. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 2006, 312:1669-1672.
66. Lartigue A., Courville P., Auquit I., Francois A., Arnoult C., Tron F., et al. Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus. J Immunol 2006, 177:1349-1354.
67. Christensen S.R., Kashgarian M., Alexopoulou L., Flavell R.A., Akira S., Shlomchik M.J. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med 2005, 202:321-331.
68. Yu P., Wellmann U., Kunder S., Quintanilla-Martinez L., Jennen L., Dear N., et al. Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE. Int Immunol 2006, 18:1211-1219.
69. Santiago-Raber M.L., Dunand-Sauthier I., Wu T., Li Q.Z., Uematsu S., Akira S., et al. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. J Autoimmun. 2010, 34:339-348.
70. Wang J., Shao Y., Bennett T.A., Shankar R.A., Wightman P.D., Reddy L.G. The functional effects of physical interactions among Toll-like receptors 7, 8, and 9. J Biol Chem 2006, 281:37427-37434.
71. Fukui R., Saitoh S., Matsumoto F., Kozuka-Hata H., Oyama M., Tabeta K., et al. Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing. J Exp Med 2009, 206:1339-1350.
72. Thibault D.L., Chu A.D., Graham K.L., Balboni I., Lee L.Y., Kohlmoos C., et al. IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice. J Clin Invest 2008, 118:1417-1426.
73. Demaria O., Pagni P.P., Traub S., de Gassart A., Branzk N., Murphy A.J., et al. TLR8 deficiency leads to autoimmunity in mice. J Clin Invest. 2010, 120:3651-3662.
74. Farina GA, York MR, Di Marzio M, Collins CA, Meller S, Homey B, et al. Poly(I:C) drives type I IFN- and TGFbeta-mediated inflammation and dermal fibrosis simulating altered gene expression in systemic sclerosis. J Invest Dermatol 130:2583-93.
75. Armstrong D.L., Reiff A., Myones B.L., Quismorio F.P., Klein-Gitelman M., McCurdy D., et al. Identification of new SLE-associated genes with a two-step Bayesian study design. Genes Immun 2009, 10:446-456.
76. Graham R.R., Kozyrev S.V., Baechler E.C., Reddy M.V., Plenge R.M., Bauer J.W., et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006, 38:550-555.
77. Shen N., Fu Q., Deng Y., Qian X., Zhao J., Kaufman K.M., et al. Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci U S A. 2010, 107:15838-15843.
78. Isnardi I., Ng Y.S., Srdanovic I., Motaghedi R., Rudchenko S., von Bernuth H., et al. IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity 2008, 29:746-757.
79. Deapen D., Escalante A., Weinrib L., Horwitz D., Bachman B., Roy-Burman P., et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992, 35:311-318.
80. Herrmann M., Voll R.E., Zoller O.M., Hagenhofer M., Ponner B.B., Kalden J.R. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998, 41:1241-1250.
81. Rodriguez-Manzanet R., Sanjuan M.A., Wu H.Y., Quintana F.J., Xiao S., Anderson A.C., et al. T and B cell hyperactivity and autoimmunity associated with niche-specific defects in apoptotic body clearance in TIM-4-deficient mice. Proc Natl Acad Sci U S A. 2010, 107:8706-8711.
82. Lu Q., Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 2001, 293:306-311.
83. Rothlin C.V., Ghosh S., Zuniga E.I., Oldstone M.B., Lemke G. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 2007, 131:1124-1136.
84. Ansel J.C., Mountz J., Steinberg A.D., DeFabo E., Green I. Effects of UV radiation on autoimmune strains of mice: increased mortality and accelerated autoimmunity in BXSB male mice. J Invest Dermatol 1985, 85:181-186.
85. Menke J., Hsu M.Y., Byrne K.T., Lucas J.A., Rabacal W.A., Croker B.P., et al. Sunlight triggers cutaneous lupus through a CSF-1-dependent mechanism in MRL-Fas(lpr) mice. J Immunol 2008, 181:7367-7379.
86. Reefman E., de Jong M.C., Kuiper H., Jonkman M.F., Limburg P.C., Kallenberg C.G., et al. Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus?. Arthritis Res Ther 2006, 8:R156.
87. Reefman E., Kuiper H., Limburg P.C., Kallenberg C.G., Bijl M. Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients. Ann Rheum Dis 2008, 67:11-18.
88. Furukawa F., Kashihara-Sawami M., Lyons M.B., Norris D.A. Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus. J Invest Dermatol 1990, 94:77-85.
89. Savarese E., Steinberg C., Pawar R.D., Reindl W., Akira S., Anders H.J., et al. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis. Arthritis Rheum 2008, 58:1107-1115.
90. Baudino L., Yoshinobu K., Dunand-Sauthier I., Evans L.H., Izui S. TLR-mediated up-regulation of serum retroviral gp70 is controlled by the Sgp loci of lupus-prone mice. J Autoimmun. 2010, 35:153-159.
91. Stetson D.B., Ko J.S., Heidmann T., Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008, 134:587-598.
92. Lee-Kirsch M.A., Gong M., Chowdhury D., Senenko L., Engel K., Lee Y.A., et al. Mutations in the gene encoding the 3'-5'DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 2007, 39:1065-1067.
93. Hakkim A., Furnrohr B.G., Amann K., Laube B., Abed U.A., Brinkmann V., et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A. 2010, 107:9813-9818.
94. Kurilla M.G., Keene J.D. The leader RNA of vesicular stomatitis virus is bound by a cellular protein reactive with anti-La lupus antibodies. Cell 1983, 34:837-845.
95. Hardgrave K.L., Neas B.R., Scofield R.H., Harley J.B. Antibodies to vesicular stomatitis virus proteins in patients with systemic lupus erythematosus and in normal subjects. Arthritis Rheum 1993, 36:962-970.
96. Huang S.C., Pan Z., Kurien B.T., James J.A., Harley J.B., Scofield R.H. Immunization with vesicular stomatitis virus nucleocapsid protein induces autoantibodies to the 60kD Ro ribonucleoprotein particle. J Investig Med 1995, 43:151-158.
97. Routsias J.G., Sakarellos-Daitsiotis M., Detsikas E., Tzioufas A.G., Sakarellos C., Moutsopoulos H.M. Antibodies to EYRKK vesicular stomatitis virus-related peptide account only for a minority of anti-Ro60kD antibodies. Clin Exp Immunol 1994, 98:414-418.
98. Lerner M.R., Andrews N.C., Miller G., Steitz J.A. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 1981, 78:805-809.
99. Lenert P., Yasuda K., Busconi L., Nelson P., Fleenor C., Ratnabalasuriar R.S., et al. DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo. Arthritis Res Ther 2009, 11:R79.
100. Guiducci C., Gong M., Xu Z., Gill M., Chaussabel D., Meeker T., et al. TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus. Nature 2010, 465:937-941.